Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma;Recuperación parcial de la función renal tras trasplante autólogo en paciente con enfermedad renal crónica y mieloma múltiple

Nefrologia

Volumn 31, Issue 2, 2011, Pages 238-240

  de Alarcon Jimenez R M ^a   Meroño, S Roca ^a   Fernández, G M Álvarez ^a   Hernández, M A García ^a   Parreño, M J Navarro ^a   Griñó, C Jimeno ^a   Pedrinaci, E Zarco ^a   Núñez, M Molina ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; PARAPROTEIN; PYRAZINE DERIVATIVE;

ACUTE KIDNEY FAILURE; AUTOTRANSPLANTATION; BIOSYNTHESIS; CASE REPORT; CHRONIC DISEASE; DOWN REGULATION; DRUG EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KIDNEY DISEASE; LETTER; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; PATHOPHYSIOLOGY; REMISSION; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOWN-REGULATION; DOXORUBICIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; KIDNEY DISEASES; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; MYELOMA PROTEINS; PYRAZINES; REMISSION INDUCTION; RENAL DIALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 79955116391     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Aug.10496     Document Type: Letter

References (12)

1. García Sanz R, Mateos MV, San Migue JF. Mieloma múltiple. Med Clin (Barc) 2007;129:104-15.
2. Greipp PR, San Miguel JF, Durie BGM, et al. International Staging System for Multiple Myeloma. J Clin Onco 2005;23:3412-20.
3. Knudsen LM, Nielsen B, Gimsing P, et al. Autologous stem cell trasplantation in multiple myeloma: outcome in patients with renal failure. Eur J Haemato 2005;75:27-33.
4. Badros A, Balorgie B, Siegel E, et al Results of autologous stem cell transplant in multiple myeloma patients with rena failure. Br J Haematol 201;114:822-9.
5. Blade J, Rosinol L. Renal, hematologic and nfections complications in múltiple myeloma. Best Pract Res Clin Haemato 2005;18:635-52.
6. Irish AB, Winearls CG, Littlewood T. Presentation and supervival of patients with severe renal failure and myeloma. Q J Med 1997;90:773-80.
7. Bernardo J, González G, Hernández L Tratamiento del mieloma múltiple con talidomida y dexametasona: avanzando entamente. Med Clin (Barc) 2007;128(4):133-4.
8. Ashser A, Chanan-Khan A, Kaufman J, et al. Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study. Blood 2007; 109:2604-6.
9. Qayum A, Aleem A, Rehman A, et al. Rapid improvemente in renal function in patients with multiple myeloma and renal failure treated with bortezomib. Saudi J Kidney Dis Transp 2010;21(1):63-8.
10. Alexanian R, Barlogie B, Dixon D, et al Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990;150:1693-5.
11. Tauro S, Clark FJ, Duncan N, et al. Recovery of renal function after autologous stem cell trasplantation in myeloma patients with end-stage rena failure. Bone Marrow Transplant 2002;30:471-3.
12. Matsue K, Fujiwara H, Iwama K, et al. Reversal of dialysis-dependent renal in patients with advanced multiple myeloma single institutional experiences over 8 years. Ann Hematol 2010;89:291-7.